HOME >> BIOLOGY >> NEWS
Joslin Diabetes Center partners with Fremont Medical Center in Las Vegas

BOSTON--Joslin Diabetes Center, the global leader in diabetes research, care and education, has announced its partnership with Fremont Medical Center, a leading healthcare provider in Las Vegas, Nevada. Fremont Medical Center consists of 11 medical centers in the Las Vegas Valley, serving over 275,000 patients annually in six specialties, ranging from primary care and pediatrics to hospital in-patient care and emergency medicine. The Joslin Diabetes Center Affiliate at Fremont Medical Center, which opened Jan. 16, offers the latest advances for treating diabetes and its complications as well as patient education and support services.

"Over 100,000 people in Las Vegas have diabetes, and statistically, a third of them don't know they have the disease," said John W. Hare, M.D., Director of Joslin's Affiliated Centers Program. "We look forward to working with the professionals at Fremont Medical Center to bring Joslin's integrated, state-of-the-art care to people with diabetes and related conditions in the region."

"We are proud to bring the world-renowned leader in diabetes care and education to the Las Vegas Valley. Diabetes is a major disease affecting our local community at a rate that exceeds both state and national norms. If not properly treated, it can be a life threatening and debilitating. We look forward to working with the Joslin staff in Boston to ensure that our care meets the standards of this international leader in diabetes treatment, research and education," says James Snyder, M.D., Medical Director of the new Joslin Affiliate and a board-certified endocrinologist.

About the New Affiliate

The Joslin Diabetes Center Affiliate at Fremont Medical Center is located at 9280 W. Sunset Road, Suite 200, in the Southern Hills Hospital Medical Office Building. The Center offers diabetes training, diagnosis, treatment and support services.

This multidisciplinary program includes the services of an endocrinologist, a
'"/>


24-Feb-2006


Page: 1 2

Related biology news :

1. Joslin study indicates insulin receptors play a critical role in promoting islet growth
2. Joslin researchers discover a surprising culprit in the search for causes of diabetic birth defects
3. Joslin study reveals how a specific fat type can protect against weight gain and diabetes
4. Joslin discovers protein that causes blood vessel leakage and swelling with diabetic retinopathy
5. Joslin-led study uncovers role of appetite hormone MCH in insulin production
6. Joslin Diabetes Center study examines insulin pump therapy in adolescents
7. Joslin Diabetes Center in Boston establishes first affiliate in Canada
8. Walgreens and Joslin Diabetes Center form broad alliance to improve diabetes outcomes
9. Joslin awards Victory Medal to New York man living 75 years with type 1 diabetes
10. Joslins new book demystifies nutrition and meal planning for people with diabetes
11. Joslin study refutes recent report that bone marrow can replenish female oocytes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... ... had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in ... Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
(Date:6/23/2020)... MILTON KEYNES, England (PRWEB) , ... June 23, ... ... operations in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and ... rapid response project to support testing operations in the fight against the COVID-19 ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... SOUTH RIDING, Va. (PRWEB) , ... September 01, ... ... search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement ... Technologies . Averill will be responsible for leading all financial operations and implementing ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... 29, 2020 , ... eSource has long been touted as the solution to ... of eSource, the reasons it did not take off as quickly as people initially ... industry is moving towards capturing data electronically for clinical trials and then repurposing it ...
Breaking Biology Technology:
Cached News: